The Siegfried Group LLP in Texas

Siegfried expands national presence with addition of a Dallas-Fort Worth Market

WILMINGTON, Del., July 29, 2025 /PRNewswire/ — The Siegfried Group, LLP (Siegfried) is pleased to announce it has opened a Dallas-Fort Worth (DFW) market, representing a significant milestone in the Firm’s strategic growth. DFW becomes Siegfried’s 19th market and a key addition to its South region, which includes Houston, TX; Charlotte, NC; Atlanta, GA; and […]

Siegfried expands national presence with addition of a Dallas-Fort Worth Market Read Post »

Press
LG E and KU Logo

LG&E and KU reach agreement with several key stakeholders on plans to meet Kentucky’s growing energy needs

Stipulation agreement with several intervening parties in the utilities’ CPCN case was filed today with the Kentucky Public Service Commission LOUISVILLE, Ky., July 29, 2025 /PRNewswire/ — Louisville Gas and Electric Company, Kentucky Utilities Company and several intervening parties involved in the utilities’ current request before the Kentucky Public Service Commission to add new generation have reached

LG&E and KU reach agreement with several key stakeholders on plans to meet Kentucky’s growing energy needs Read Post »

Press
blackline company logo

BlackLine включает Грега Хьюза в совет директоров, расширяя опыт в области корпоративного ПО и стратегического роста

ЛОС-АНДЖЕЛЕС, 29 июля 2025 г. /PRNewswire/ — Сегодня BlackLine, Inc. (Nasdaq: BL), перспективная платформа для финансовых операций офиса финансового директора, объявила о включении Грега Хьюза (Greg Hughes) с 25 июля 2025 года в совет директоров. Хьюз, опытный руководитель в сфере корпоративного ПО, обладает многолетним опытом проведения масштабных стратегических преобразований. Перед этим назначением Хьюз занимал должность генерального

BlackLine включает Грега Хьюза в совет директоров, расширяя опыт в области корпоративного ПО и стратегического роста Read Post »

Press
Quad Wordmark Logo

Quad Reports Second Quarter and Year-to-Date 2025 Results

Reaffirms Full-Year 2025 Financial Guidance Continues Investing in Strategic Growth Areas — Data and Audience Intelligence, AI-Enabled Tools and Systems, and In-Store Retail Media Network SUSSEX, Wisc., July 29, 2025 /PRNewswire/ — Quad/Graphics, Inc. (NYSE: QUAD) (“Quad” or the “Company”), a marketing experience company that solves complex marketing challenges for its clients, today reported results

Quad Reports Second Quarter and Year-to-Date 2025 Results Read Post »

Press
STARZ Logo

STARZ TO RELEASE SECOND QUARTER EARNINGS FOR CALENDAR 2025 AND HOLD ANALYST AND INVESTOR CONFERENCE CALL FOLLOWING MARKET CLOSE ON THURSDAY, AUGUST 14

SANTA MONICA, Calif., July 29, 2025 /PRNewswire/ — STARZ (Nasdaq: STRZ) announced today the company will report its second quarter financial results for calendar 2025, ended June 30, 2025, on Thursday, August 14. Senior management will participate in an analyst and investor call to discuss results at 2:00PM PT/5:00PM ET following market close on August 14.

STARZ TO RELEASE SECOND QUARTER EARNINGS FOR CALENDAR 2025 AND HOLD ANALYST AND INVESTOR CONFERENCE CALL FOLLOWING MARKET CLOSE ON THURSDAY, AUGUST 14 Read Post »

Press
HMI PSI Logo

HMI & PSI – Announce Strategic Alliance to Provide Advanced Materials & Innovative Engineering Solutions for Global Mining & Strategic Infrastructure Sectors

The HMI Company (Manitowoc WI) and The PSI Group of Companies (Saskatoon SK) are leveraging their leading technological and industrial strengths to provide the global mining, utilities and strategic infrastructure sectors new, advanced products and associated, state-of-the-art engineering solutions. HMI, an innovation-driven company which formulates and manufactures specialized industrial polyurethane products, and the PSI Group

HMI & PSI – Announce Strategic Alliance to Provide Advanced Materials & Innovative Engineering Solutions for Global Mining & Strategic Infrastructure Sectors Read Post »

Press
Kedrion Biopharma Logo

Kedrion Biopharma Receives Orphan Drug Designation for COAGADEX® for Acquired Factor X Deficiency (aFXD) and Starts Clinical Trial to Evaluate Efficacy and Safety

FORT LEE, N.J., July 29, 2025 /PRNewswire/ — Kedrion Biopharma is proud to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Coagulation Factor X human (tradename COAGADEX) for the treatment of acquired Factor X Deficiency (aFXD), a rare hematologic disorder with a global prevalence of < 1

Kedrion Biopharma Receives Orphan Drug Designation for COAGADEX® for Acquired Factor X Deficiency (aFXD) and Starts Clinical Trial to Evaluate Efficacy and Safety Read Post »

Press
Scroll to Top